Advice on standard assessment for diagnosing dementia

Internationally renowned experts in dementia and cognitive assessment, including researchers from UNSW Sydney’s Center for Healthy Brain Aging (CHeBA), have provided expert opinion on the development of a standard set of neuropsychological tests for patients presenting to memory clinics, to ensure consistency in diagnosis of Mild Cognitive Impairment and dementia. The invited experts, which included […]

Continue Reading

People with newly diagnosed Alzheimer’s disease less likely to have cataract surgery than unaffected people

People with Alzheimer’s disease (AD) are less likely to have cataract surgery than people without Alzheimer’s disease. The procedure rate starts to decrease already one year after the diagnosis, according to a new study from the University of Eastern Finland. The lower likelihood of cataract surgery among people with cognitive disorders has been reported previously. […]

Continue Reading

Invasive brain-computer interfaces use thoughts to bring prostheses to life

Invasive brain-computer interfaces aim to improve the quality of life of severely paralyzed patients. Movement intentions are read out in the brain, and this information is used to control robotic limbs. A research team at the Knappschaftskrankenhaus Bochum Langendreer, University Clinic of Ruhr-Universit├Ąt Bochum, has examined which errors can occur during communication between the brain […]

Continue Reading

Active community voice effective tool for population health improvement, study reports

Health care providers and public health and social services agencies who include the community members they serve in collaborative activities, a practice called “community voice,” will improve health equity and progress in meeting communities’ health goals and needs according to researchers at Georgia State University’s Georgia Health Policy Center (GHPC). In a new study, co-authors […]

Continue Reading

Why Australia should reschedule MDMA and psilocybin for the treatment of mental illness

The Therapeutic Goods Administration (TGA) is considering rescheduling psilocybin and MDMA from their current classification as Schedule 9 prohibited substances to Schedule 8 controlled substances. This would allow psychiatrists to use these drugs in combination with psychotherapy for the treatment of conditions such as depression and post-traumatic stress disorder (PTSD). Here’s why we believe that […]

Continue Reading